NDC Pharmacologic Class N0000175545 Oxidation-Reduction Activity [MoA]
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0037-6321 | Urelle | Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, And Sodium Phosphate, Monobasic, Monohydrate | Tablet | Oral | Meda Pharmaceuticals | Human Prescription Drug |
0178-0513 | Utira-c | Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, Hyoscyamine Sulfate | Tablet | Oral | Mission Pharmacal Company | Human Prescription Drug |
0178-0740 | Uribel | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate | Capsule | Oral | Mission Pharmacal Company | Human Prescription Drug |
0485-0151 | Urogesic Blue | Methenamine, Sodium Phosphate, Monobasic, Methylene Blue, And Hyoscyamine Sulfate | Tablet, Coated | Oral | Edwards Pharmaceuticals, Inc. | Human Prescription Drug |
0517-0125 | Provayblue | Methylene Blue | Injection | Intravenous | American Regent, Inc. | Human Prescription Drug |
0517-0374 | Provayblue | Methylene Blue | Injection | Intravenous | American Regent, Inc. | Human Prescription Drug |
0682-0334 | Urimar-t | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate | Tablet | Oral | Marnel Pharmaceuticals, Llc | Human Prescription Drug |
17478-504 | Methylene Blue | Methylene Blue | Injection | Intravenous | Akorn, Inc. | Human Prescription Drug |
42291-851 | Uroav-81 | Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue And Hyoscyamine Sulfate | Tablet | Oral | Avkare | Human Prescription Drug |
42291-852 | Uroav-b | Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue And Hyoscyamine Sulfate | Capsule | Oral | Avkare | Human Prescription Drug |
44523-741 | Hyophen | Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate | Tablet | Oral | Biocomp Pharma, Inc. | Human Prescription Drug |
44523-742 | Phosphasal | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate | Tablet | Oral | Biocomp Pharma | Human Prescription Drug |
44523-743 | Ustell | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate | Capsule | Oral | Biocomp Pharma, Inc. | Human Prescription Drug |
58657-454 | Me Naphos Mb Hyo 1 | Urinary Antiseptic Antispasmodic | Tablet | Oral | Method Pharmaceuticals | Human Prescription Drug |
58657-456 | Uro-mp | Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue And Hyoscyamine Sulfate | Capsule | Oral | Method Pharmaceuticals, Llc | Human Prescription Drug |
58657-458 | Uro-458 | Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue And Hyoscyamine Sulfate | Tablet | Oral | Method Pharmaceuticals, Llc | Human Prescription Drug |
There are 16 NDC products with the pharmacologic class Oxidation-Reduction Activity [MoA].